AI-generated summary
The authors report a two-year randomised study of 108 premyopic children comparing repeated red light therapy with a control group. The treatment group showed less axial length elongation and less myopic refractive progression, and a rebound in axial length growth was seen after treatment was stopped in the second year. The abstract does not state a limitation about the study design beyond the reported confidence intervals.
- Participants
- 108
- Who or what was studied
- Children with premyopia (cycloplegia spherical equivalent refraction -0.50 to +0.75 D)
- Limits stated in the abstract
- The abstract reports wide confidence intervals for some subgroup and choroidal thickness estimates and does not describe blinding or long-term follow-up beyond two years.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on bjo.bmj.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Red light therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.